M. Holtkamp
Impact in
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
-
- PARP inhibition in cancer therapy
- Cancer Treatment and Pharmacology
Papers in
- Oncology 9
- Cancer Treatment and Pharmacology 4
- PARP inhibition in cancer therapy 2
- Neutropenia and Cancer Infections 2
- Co-authors
- Sjoerd Rodenhuis (10 shared papers)Jan H. Schornagel (4 shared papers)Jos H. Beijnen (3 shared papers)I. C. M. Slaper-Cortenbach (4 shared papers)Alwin D. R. Huitema (3 shared papers)Elsken van der Wall (2 shared papers)W J Nooijen (2 shared papers)Joke W. Baars (4 shared papers)
- Journals
- Annals of Oncology (4 papers)British Journal of Cancer (1 paper)Journal of Clinical Oncology (1 paper)The Breast Journal (1 paper)Therapeutic Drug Monitoring (1 paper)
- Partner nations
- Netherlands
In The Last Decade
M. Holtkamp
13 papers receiving 433 citations
Peers
Comparison fields: 5 of 65
- Hematology 99
- Oncology 220
- Pathology and Forensic Medicine 98
- Cancer Research 81
- Genetics 80
Countries citing papers authored by M. Holtkamp
This map shows the geographic impact of M. Holtkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Holtkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Holtkamp more than expected).
Fields of papers citing papers by M. Holtkamp
This network shows the impact of papers produced by M. Holtkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Holtkamp. The network helps show where M. Holtkamp may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Holtkamp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 126 | |
| 2 | 1996 | 81 | |
| 3 | 1994 | 56 | |
| 4 | 2005 | 52 | |
| 5 | 2002 | 51 | |
| 6 | 2003 | 20 | |
| 7 | 1999 | 12 | |
| 8 | 2009 | 11 | |
| 9 | 2013 | 11 | |
| 10 | Mobilisation of blood progenitor cells with ifosfamide and etoposide (VP-16) in combination with recombinant human G-CSF (Filgrastim) in patients with malignant lymphomas or solid tumours. | 1996 | 8 |
| 11 | 2009 | 8 | |
| 12 | 1997 | 5 | |
| 13 | 2017 | 1 |
About M. Holtkamp
M. Holtkamp is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Pharmacology, having authored 13 papers that have together received 442 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), BRCA gene mutations in cancer (2 papers), PARP inhibition in cancer therapy (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Cancer Genomics and Diagnostics (2 papers), Central Venous Catheters and Hemodialysis (2 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Hematology (99 citations), Oncology (220 citations), Pathology and Forensic Medicine (98 citations), Cancer Research (81 citations) and Genetics (80 citations). M. Holtkamp has collaborated with scholars based in Netherlands. Frequent co-authors include Sjoerd Rodenhuis, Jan H. Schornagel, Jos H. Beijnen, I. C. M. Slaper-Cortenbach, Alwin D. R. Huitema, Elsken van der Wall, W J Nooijen, Joke W. Baars, Jolanda Schrama and Matthijs M. Tibben. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, Journal of Clinical Oncology, The Breast Journal and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.